Portal de Periódicos da CAPES

Guía para el tratamiento preventivo del ictus isquémico y AIT (II). Recomendaciones según subtipo etiológico

2011; Elsevier BV; Volume: 29; Issue: 3 Linguagem: Inglês

10.1016/j.nrl.2011.06.003

1697-1264

Blanca Fuentes, J. Gállego, Antonio Gil-Núñez, A. Morales, Francisco Purroy, Jaume Roquer, Tomás Segura, J. Tejada, Aída Lago, Exuperio Díez–Tejedor, María Alonso de Leciñana, José Álvarez‐Sabín, Juan F. Arenillas, S. Calleja, I. Casado, Mar Castellanos, José Castillo, A. Dávalos, Fernando Díaz‐Otero, J. Egido, J.C. López-Fernández, Marimar Freijó, Á. García Pastor, F. Gilo, Pablo Irimia, J. Maestre, Jaime Masjuán, Joan Martí‐Fàbregas, Patricia Martínez‐Sánchez, Eduardo Martínez‐Vila, Carlos A. Molina, Florentino Nombela, Marc Ribó, Manuel Rodríguez‐Yáñez, Francisco R. Rubio, Joaquı́n Serena, P. Simal, José Vivancos,

Atrial Fibrillation Management and Outcomes

To update the ad hoc Committee of the Cerebrovascular Diseases Study Group of The Spanish Neurological Society guidelines on prevention of ischaemic stroke (IS) and Transient Ischaemic Attack (TIA).We reviewed the available evidence on ischaemic stroke and TIA prevention according to aetiological subtype. Levels of evidence and recommendation levels are based on the classification of the Centre for Evidence-Based Medicine.In atherothrombotic IS, antiplatelet therapy and revascularization procedures in selected cases of ipsilateral carotid stenosis (70%-90%) reduce the risk of recurrences. In cardioembolic IS (atrial fibrillation, valvular diseases, prosthetic valves and myocardial infarction with mural thrombus) prevention is based on the use of oral anticoagulants. Preventive therapies for uncommon causes of IS will depend on the aetiology. In the case of cerebral venous thrombosis oral anticoagulation is effective.We conclude with recommendations for clinical practice in prevention of IS according to the aetiological subtype presented by the patient.